Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AVTX
AVTX logo

AVTX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

AVTX News

Avalo Therapeutics Q1 Earnings Beat Expectations with Strong Cash Position

May 13 2026seekingalpha

Avalo to Offer 19.73 Million Shares at $17.75 Each

May 06 2026stocktwits

Avalo Therapeutics Prices Public Offering at $375M

May 06 2026seekingalpha

Avalo Therapeutics Prices Public Offering at $17.75 per Share

May 06 2026Newsfilter

Avalo Plans to Advance Abdakibart into Late-Stage Registration

May 05 2026stocktwits

Avalo Therapeutics Reports FY EPS Beat Despite Revenue Decline

Mar 23 2026seekingalpha

Avalo Therapeutics Completes Enrollment for AVTX-009 Trial

Feb 02 2026Benzinga

Valvoline Analyst Starts Coverage Optimistically; Check Out Thursday's Top 5 Initiations

Dec 18 2025Benzinga

AVTX Events

05/28 08:50
Liquid Option Borrow Rates Rise: PSEC 6.65%
Latest data shows the largest indicative borrow rate increases among liquid option names include: Prospect Capital (PSEC) 6.65% +3.79, Angion Biomedica Corp (ELTX) 13.52% +1.76, GRANITESHARES 2X LONG MU DAILY ETF (MULL) 13.12% +1.61, Vivopower Plc (VIVO) 16.76% +0.70, Avalo Therapeutics (AVTX) 1.18% +0.65, KULR Technology Group (KULR) 6.76% +0.54, CPS Technologies (CPSH) 6.12% +0.52, Tradr 2X Long SNDK Daily ETF (SNXX) 8.43% +0.49, ASP Isotopes Inc (ASPI) 1.76% +0.38, and Boost Run Inc. (BRUN) 8.40% +0.38.

AVTX Monitor News

Avalo Therapeutics Prices Public Offering at $17.75 per Share

May 06 2026

AVTX Earnings Analysis

No Data

No Data

People Also Watch